FDA agrees to meeting with Enochian over HIV therapy
The US authority has said yes to a meeting with Enochian Biosciences to discuss a potential start to clinical trials of the company's HIV treatment. The biotech company is also looking to raise funds.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT
Enochian Biosciences has secured a meeting with the US Food and Drug Administration (FDA). This means the company is sticking to its previously announced schedule, which predicted discussions with the authority would start in 2021.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.